
Beclomethasone Dipropionate
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Partnering with Avik means gaining access to advanced corticosteroid API development, backed by deep expertise in impurity profiling, polymorphism studies, and precision micronization. With a global presence across 45+ countries and certifications from EU GMP, ANVISA, MFDS, and TFDA, Avik delivers high-value APIs with exceptional quality, compliance, and trusted service.
Avik specializes in corticosteroid API development with strong expertise in impurity profiling, polymorphism studies, and custom impurity synthesis.
EU GMP, ANVISA, MFDS, TFDA approved plant and trusted by Pharma Partners in 45+ countries, delivering specialized high value APIs and responsive service.
Lorem ipsum dolor sit amet consectetur adipisicing elit. Libero dolorum voluptate corrupti debitis fugiat dolorem quae accusamus ab veniam dolor.
Cynthia Lobo, a graduate of Mumbai University, brings with her 18 years of professional experience, including 16 years in the pharmaceutical industry. She independently manages key international markets such as Europe, CIS, and Egypt, along with several Asian countries including China, Malaysia, Sri Lanka, Taiwan, Thailand, Singapore, and Hong Kong.
Cynthia is known for building and maintaining strong, long-term relationships with customers and agents across these regions.
Mobile No: 9821827247
A marketing professional with over 20 years in the Pharmaceutical API manufacturing sector, showcasing expertise in business development. Offers comprehensive insight into the pharma landscape with strength in Customer service management, Business processes, Analytics, Forecasting and Cross functional leadership.
I have always believed that success isn’t just about numbers, it’s about impact, it’s about the lives we touch, the opportunities we create, and the differences we make along the way.
To me, leadership is about inspiring, empowering, and making a difference, because real success isn’t just about what we achieve, but about the legacy of impact, opportunity, and meaningful change we leave behind.
Mobile No: +91 -7757985269 / 8779721345
With over 35 years of experience in the pharmaceutical API manufacturing sector, I began my career in Import Documentation before moving into API & Chemical Procurement—a challenging yet highly rewarding phase. I then transitioned into Marketing, where I embraced significant challenges that not only strengthened my professional capabilities but also gave me the opportunity to work closely with both management and customers.
This journey has been deeply fulfilling, marked by continuous growth, adaptability, and a passion for delivering value. My skills have been shaped through years of dedicated practice and hands-on experience, while my achievements stand as tangible milestones of excellence within my field.
Mobile No: 9320121167
A Ph.D. in Organic Chemistry, Dr. Chheda has 25+ years of experience in R&D, manufacturing, and regulatory functions across steroidal and high-potency APIs. His expertise has played a key role in Avik’s technical and operational growth.
Neha Thakore, Chief Operating Officer at Avik Pharmaceutical, brings over 25 years of industry expertise to her role. Under her leadership, Avik has strengthened its position as a compliant manufacturer of corticosteroids. Inspired by a family legacy rooted in pharma innovation, Neha combines strategic foresight with a commitment to quality and global standards. Also serving as Vice Chairperson of the IDMA API Committee, she continues to drive Avik toward sustained growth and industry excellence.
Mr. Anant Thakore, a law graduate, entered the pharma industry during the License Raj era and played a pivotal role in shaping pro-industry policies. As IDMA President, he promoted globalization by encouraging Indian API manufacturers to engage in international trade. He grew his business into a diversified group and has mentored many across the sector. In recognition of his contributions, IDMA honoured him as "Chief Mentor of the Year" in 2016.